Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trialBrian G. Feagan, Rupert W. Leong, Marion Vetter et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 235
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studiesWalter Reinisch, Dirk Vanderschueren, Wayne J.G. Hellstrom et al.|Annals of the Rheumatic Diseases|2023Cited by 44